CEPI
@cepi.net
Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world. #100DaysMission
CEPI’s new publication lays out the blueprint for equitable access at the heart of the organisation’s outbreak R&D.
Our Pathogen Archetype Frameworks details four pathogen archetypes, which ultimately guide CEPI’s access funding, advocacy, and catalysing efforts.
Learn more in the blog ⬇️
Our Pathogen Archetype Frameworks details four pathogen archetypes, which ultimately guide CEPI’s access funding, advocacy, and catalysing efforts.
Learn more in the blog ⬇️
A blueprint for access at the heart of outbreak R&D | CEPI
Discover how the type of pathogen guides CEPI's approach to access
cepi.net
November 26, 2025 at 2:29 PM
CEPI’s new publication lays out the blueprint for equitable access at the heart of the organisation’s outbreak R&D.
Our Pathogen Archetype Frameworks details four pathogen archetypes, which ultimately guide CEPI’s access funding, advocacy, and catalysing efforts.
Learn more in the blog ⬇️
Our Pathogen Archetype Frameworks details four pathogen archetypes, which ultimately guide CEPI’s access funding, advocacy, and catalysing efforts.
Learn more in the blog ⬇️
Join WAHO, CEPI & partners for a webinar launching the Lassa Fever Research Agenda & open-access Repository—key tools to guide research, inform policy, and support timely, equitable vaccine introduction.
📅 25 Nov | 🕛 12:00 GMT
🔗 Register: bit.ly/4i8pYxT
📅 25 Nov | 🕛 12:00 GMT
🔗 Register: bit.ly/4i8pYxT
November 20, 2025 at 2:52 PM
Join WAHO, CEPI & partners for a webinar launching the Lassa Fever Research Agenda & open-access Repository—key tools to guide research, inform policy, and support timely, equitable vaccine introduction.
📅 25 Nov | 🕛 12:00 GMT
🔗 Register: bit.ly/4i8pYxT
📅 25 Nov | 🕛 12:00 GMT
🔗 Register: bit.ly/4i8pYxT
A new CEPI-funded initiative with LumaCyte
and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.
and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.
November 19, 2025 at 2:58 PM
A new CEPI-funded initiative with LumaCyte
and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.
and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.
The Regionalized Vaccine Manufacturing Collaborative (RVMC) has released its first Status Report - a major step toward building sustainable, regionally-led vaccine manufacturing across Africa, Southeast Asia, and Latin America and the Caribbean.
Progress towards regionalised vaccine manufacturing remains uneven
The Regionalised Vaccine Manufacturing Collaborative (RVMC) has published its inaugural Regionalised Vaccine Manufacturing (RVM) Status Report. Thus, marking a pivotal step in understanding progress ...
rvmc.net
November 18, 2025 at 2:32 PM
The Regionalized Vaccine Manufacturing Collaborative (RVMC) has released its first Status Report - a major step toward building sustainable, regionally-led vaccine manufacturing across Africa, Southeast Asia, and Latin America and the Caribbean.
Sterility testing — ensuring vaccine batches are free from microbial contamination — can take up to a month.
With new CEPI funding of up to $199,238, USA-based CBio will develop a rapid sterility testing system based on its cellPhoresis™ technology.
With new CEPI funding of up to $199,238, USA-based CBio will develop a rapid sterility testing system based on its cellPhoresis™ technology.
November 13, 2025 at 3:24 PM
Sterility testing — ensuring vaccine batches are free from microbial contamination — can take up to a month.
With new CEPI funding of up to $199,238, USA-based CBio will develop a rapid sterility testing system based on its cellPhoresis™ technology.
With new CEPI funding of up to $199,238, USA-based CBio will develop a rapid sterility testing system based on its cellPhoresis™ technology.
The West African Health Organization(WAHO), with support from CEPI and other partners, have launched the first-ever Lassa Fever Vaccine Policy Research Agenda.
Read in full: bit.ly/4nTNVdO
Read in full: bit.ly/4nTNVdO
November 13, 2025 at 3:00 PM
The West African Health Organization(WAHO), with support from CEPI and other partners, have launched the first-ever Lassa Fever Vaccine Policy Research Agenda.
Read in full: bit.ly/4nTNVdO
Read in full: bit.ly/4nTNVdO
The world remains dangerously underprepared for future pandemics. A new report from the G20 HLIP – co-chaired by CEPI Board Chair, Jane Halton – warns urgent action is needed to close financing gaps and strengthen defences against biological threats.
Read the full report ⬇️
Read the full report ⬇️
Pandemic Financing
The G20 High Level Independent Panel sets minimum annual benchmarks for pandemic financing and urges governments to take action by or before the September
nam.edu
November 12, 2025 at 4:00 PM
The world remains dangerously underprepared for future pandemics. A new report from the G20 HLIP – co-chaired by CEPI Board Chair, Jane Halton – warns urgent action is needed to close financing gaps and strengthen defences against biological threats.
Read the full report ⬇️
Read the full report ⬇️
CEPI is truly honoured to receive Research!America’s 2026 Advocacy Award for Outstanding Achievement in Public Health.
The award recognises a public–private partnership that has made a critical and timely contribution to public health progress ⬇️
The award recognises a public–private partnership that has made a critical and timely contribution to public health progress ⬇️
Research!America Announces 2026 Advocacy Awards to Honor Nation’s Top Medical and Health Leaders - Research!America
Research!America urges the president and congressional leaders to come back to the table immediately to end the shutdown.
www.researchamerica.org
November 11, 2025 at 3:57 PM
CEPI is truly honoured to receive Research!America’s 2026 Advocacy Award for Outstanding Achievement in Public Health.
The award recognises a public–private partnership that has made a critical and timely contribution to public health progress ⬇️
The award recognises a public–private partnership that has made a critical and timely contribution to public health progress ⬇️
What do you know about CEPI's 100 Days Mission?
More than eight million people who died during the COVID-19 pandemic might be alive today if the world had achieved the 100 Days Mission to develop safe and effective new vaccines against the novel SARS-SoV-2 virus.
More than eight million people who died during the COVID-19 pandemic might be alive today if the world had achieved the 100 Days Mission to develop safe and effective new vaccines against the novel SARS-SoV-2 virus.
What would it take to achieve the 100 Days Mission?
What will it take for the world to develop, and enable access to safe and effective vaccines against new pathogens in 100 days? And why is it crucial that the world…
vimeo.com
November 7, 2025 at 3:09 PM
What do you know about CEPI's 100 Days Mission?
More than eight million people who died during the COVID-19 pandemic might be alive today if the world had achieved the 100 Days Mission to develop safe and effective new vaccines against the novel SARS-SoV-2 virus.
More than eight million people who died during the COVID-19 pandemic might be alive today if the world had achieved the 100 Days Mission to develop safe and effective new vaccines against the novel SARS-SoV-2 virus.
💡West Africa is one step closer to being protected against the deadly Lassa fever disease with IAVI's vaccine candidate, supported by CEPI, showing promise in the first stage of clinical testing.
Results from the Phase I trial are published in @nejm.org.
Results from the Phase I trial are published in @nejm.org.
IAVI’s Lassa fever vaccine shows promise in early clinical trials | CEPI
CEPI-backed research testing the vaccine candidate's safety and immunogenicity was published in the New England Journal of Medicine.
cepi.net
November 6, 2025 at 4:18 PM
💡West Africa is one step closer to being protected against the deadly Lassa fever disease with IAVI's vaccine candidate, supported by CEPI, showing promise in the first stage of clinical testing.
Results from the Phase I trial are published in @nejm.org.
Results from the Phase I trial are published in @nejm.org.
Broadly protective coronavirus vaccines could offer an alternative to the ‘one bug, one drug' approach.
We spoke to Dr Michael Osterholm, Director of CIDRAP, about a new CEPI-funded initiative mapping out research into all-in-one coronavirus vaccines ⬇️
cepi.net/big-one-comi...
We spoke to Dr Michael Osterholm, Director of CIDRAP, about a new CEPI-funded initiative mapping out research into all-in-one coronavirus vaccines ⬇️
cepi.net/big-one-comi...
The ‘Big One’ is coming: How can we prepare for a future coronavirus pandemic? | CEPI
Broadly protective coronavirus vaccines, built to protect us from multiple different future coronaviruses in one vaccine, could offer a vital
cepi.net
November 4, 2025 at 1:26 PM
Broadly protective coronavirus vaccines could offer an alternative to the ‘one bug, one drug' approach.
We spoke to Dr Michael Osterholm, Director of CIDRAP, about a new CEPI-funded initiative mapping out research into all-in-one coronavirus vaccines ⬇️
cepi.net/big-one-comi...
We spoke to Dr Michael Osterholm, Director of CIDRAP, about a new CEPI-funded initiative mapping out research into all-in-one coronavirus vaccines ⬇️
cepi.net/big-one-comi...
A busy month in the world of epidemic and pandemic preparedness ⬇️
Explore CEPI's October newsletter to discover how Germany is helping boost global health security, our latest R&D and manufacturing partnerships, and all the other usual features, too.
Explore CEPI's October newsletter to discover how Germany is helping boost global health security, our latest R&D and manufacturing partnerships, and all the other usual features, too.
Germany fortifies the global pandemic shield with new pledge to CEPI
October delivered a significant boost to global epidemic and pandemic preparedness as Germany strengthened its backing for CEPI, reaffirming its global health leadership with a new EUR 100 million fiv...
www.linkedin.com
October 31, 2025 at 1:54 PM
A busy month in the world of epidemic and pandemic preparedness ⬇️
Explore CEPI's October newsletter to discover how Germany is helping boost global health security, our latest R&D and manufacturing partnerships, and all the other usual features, too.
Explore CEPI's October newsletter to discover how Germany is helping boost global health security, our latest R&D and manufacturing partnerships, and all the other usual features, too.
Reposted by CEPI
One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as CEPI, the University of Oxford and Serum Institute of India collaborate to create the world’s largest investigational ready reserve of a Nipah virus vaccine candidate.
Establishing the world’s largest Nipah virus vaccine reserve | CEPI
CEPI, Serum Institute of India and the University of Oxford collaborate to manufacture ChAdOx1 NipahB vaccines for Phase II trials and
cepi.net
October 28, 2025 at 4:38 PM
One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as CEPI, the University of Oxford and Serum Institute of India collaborate to create the world’s largest investigational ready reserve of a Nipah virus vaccine candidate.
One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as CEPI, the University of Oxford and Serum Institute of India collaborate to create the world’s largest investigational ready reserve of a Nipah virus vaccine candidate.
Establishing the world’s largest Nipah virus vaccine reserve | CEPI
CEPI, Serum Institute of India and the University of Oxford collaborate to manufacture ChAdOx1 NipahB vaccines for Phase II trials and
cepi.net
October 28, 2025 at 4:38 PM
One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as CEPI, the University of Oxford and Serum Institute of India collaborate to create the world’s largest investigational ready reserve of a Nipah virus vaccine candidate.
New CEPI-funded project will harness innovative microbial testing methods to accelerate vaccine sterility testing from weeks to days.
CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.
CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.
October 22, 2025 at 10:33 AM
New CEPI-funded project will harness innovative microbial testing methods to accelerate vaccine sterility testing from weeks to days.
CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.
CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.
Last month, Health Emergencies Response Canada (HERC) and CEPI co-chaired a roundtable in Ottawa with organisations funding and delivering R&D for diagnostics, vaccines and therapeutics for epidemic and pandemic threats.
October 21, 2025 at 3:38 PM
Last month, Health Emergencies Response Canada (HERC) and CEPI co-chaired a roundtable in Ottawa with organisations funding and delivering R&D for diagnostics, vaccines and therapeutics for epidemic and pandemic threats.
Following the recent framework agreement with Fondation Mérieux, CEPI is also partnering with the @ukhsa.bsky.social to support biosecurity capacity strengthening with national public health institutions and universities involved in epidemic preparedness and infectious disease research across DRC.
October 17, 2025 at 2:00 PM
Following the recent framework agreement with Fondation Mérieux, CEPI is also partnering with the @ukhsa.bsky.social to support biosecurity capacity strengthening with national public health institutions and universities involved in epidemic preparedness and infectious disease research across DRC.
New CEPI-funded project will partner with Austria’s GENSPEED Biotech to repurpose its GENSPEED R2 device to create a fast, fully automated quality control test for detecting residual HEK293 host cell proteins, a critical step in ensuring vaccine safety and consistency.
October 17, 2025 at 10:20 AM
New CEPI-funded project will partner with Austria’s GENSPEED Biotech to repurpose its GENSPEED R2 device to create a fast, fully automated quality control test for detecting residual HEK293 host cell proteins, a critical step in ensuring vaccine safety and consistency.
Reposted by CEPI
CEPI and Serum Institute of India Pvt. Ltd. (SII)—the world’s largest vaccine manufacturer—are collaborating to boost pandemic response preparedness using a baculovirus vaccine platform to target H5N1 bird flu as a prototype for a potential Disease X.
Serum Institute of India and CEPI supercharge pandemic response preparedness targeting H5N1 | CEPI
Project will contribute to global preparedness for pandemic influenza and support faster responses against other emerging viral threats.
cepi.net
October 14, 2025 at 8:19 AM
CEPI and Serum Institute of India Pvt. Ltd. (SII)—the world’s largest vaccine manufacturer—are collaborating to boost pandemic response preparedness using a baculovirus vaccine platform to target H5N1 bird flu as a prototype for a potential Disease X.
A packed room and lively discussion marked CEPI’s
@worldhealthsummit.bsky.social panel “Preparing for Future Pandemics – From Fragmentation to Cohesion.”
➡️ Watch in full here: bit.ly/42uCAsS
Or see the toplines and what else CEPI got up to at this year's WHS 👇
@worldhealthsummit.bsky.social panel “Preparing for Future Pandemics – From Fragmentation to Cohesion.”
➡️ Watch in full here: bit.ly/42uCAsS
Or see the toplines and what else CEPI got up to at this year's WHS 👇
A packed room and lively discussion marked CEPI’s World Health Summit session, “Preparing for Future Pandemics – From Fragmentation to Cohesion.”
The panel was chaired by CEPI CEO Richard Hatchett… |...
A packed room and lively discussion marked CEPI’s World Health Summit session, “Preparing for Future Pandemics – From Fragmentation to Cohesion.”
The panel was chaired by CEPI CEO Richard Hatchett an...
www.linkedin.com
October 15, 2025 at 1:41 PM
A packed room and lively discussion marked CEPI’s
@worldhealthsummit.bsky.social panel “Preparing for Future Pandemics – From Fragmentation to Cohesion.”
➡️ Watch in full here: bit.ly/42uCAsS
Or see the toplines and what else CEPI got up to at this year's WHS 👇
@worldhealthsummit.bsky.social panel “Preparing for Future Pandemics – From Fragmentation to Cohesion.”
➡️ Watch in full here: bit.ly/42uCAsS
Or see the toplines and what else CEPI got up to at this year's WHS 👇
CEPI and Serum Institute of India Pvt. Ltd. (SII)—the world’s largest vaccine manufacturer—are collaborating to boost pandemic response preparedness using a baculovirus vaccine platform to target H5N1 bird flu as a prototype for a potential Disease X.
Serum Institute of India and CEPI supercharge pandemic response preparedness targeting H5N1 | CEPI
Project will contribute to global preparedness for pandemic influenza and support faster responses against other emerging viral threats.
cepi.net
October 14, 2025 at 8:19 AM
CEPI and Serum Institute of India Pvt. Ltd. (SII)—the world’s largest vaccine manufacturer—are collaborating to boost pandemic response preparedness using a baculovirus vaccine platform to target H5N1 bird flu as a prototype for a potential Disease X.
"Pandemics are not hypothetical risks. They are existential threats and defending against them is both a strategic and moral imperative.”
That was the clear message from Dorothee Bär, German Federal Minister of Research, Technology and Space & CEPI CEO @drrhatchett.bsky.social below ⬇️
That was the clear message from Dorothee Bär, German Federal Minister of Research, Technology and Space & CEPI CEO @drrhatchett.bsky.social below ⬇️
Dorothee Bär: Deutschlands Rolle bei globaler Gesundheit – „Wir werden die Wissenschaft unterstützen“ - WELT
Beim Weltgesundheitsgipfel sprechen führende Köpfe aus Politik, Wissenschaft, Wirtschaft und Zivilgesellschaft, um über zentrale Herausforderungen der globalen Gesundheit zu sprechen. Deutschland ist ...
bit.ly
October 13, 2025 at 9:25 AM
"Pandemics are not hypothetical risks. They are existential threats and defending against them is both a strategic and moral imperative.”
That was the clear message from Dorothee Bär, German Federal Minister of Research, Technology and Space & CEPI CEO @drrhatchett.bsky.social below ⬇️
That was the clear message from Dorothee Bär, German Federal Minister of Research, Technology and Space & CEPI CEO @drrhatchett.bsky.social below ⬇️
📢 Germany reaffirms its global health leadership with a EUR 100M pledge to CEPI.
This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all.
cepi.net/bmftr-boosts...
This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all.
cepi.net/bmftr-boosts...
October 12, 2025 at 2:50 PM
📢 Germany reaffirms its global health leadership with a EUR 100M pledge to CEPI.
This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all.
cepi.net/bmftr-boosts...
This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all.
cepi.net/bmftr-boosts...
📢 Die Bundesrepublik Deutschland hat ihre weltweite Vorreiterrolle im Gesundheitsbereich mit einer erneuten Zusage in Höhe von 100 Millionen Euro für CEPI bekräftigt.
October 12, 2025 at 2:45 PM
📢 Die Bundesrepublik Deutschland hat ihre weltweite Vorreiterrolle im Gesundheitsbereich mit einer erneuten Zusage in Höhe von 100 Millionen Euro für CEPI bekräftigt.
Will you be in Berlin for the @worldhealthsummit.bsky.social?
CEPI is organising a thought-provoking panel entitled “Preparing for Future Pandemics – From Fragmentation to Cohesion” on 12 October 2025, 16:00–17:30 CEST ⬇️
bit.ly/3WvE9TI
CEPI is organising a thought-provoking panel entitled “Preparing for Future Pandemics – From Fragmentation to Cohesion” on 12 October 2025, 16:00–17:30 CEST ⬇️
bit.ly/3WvE9TI
World Health Summit
The World Health Summit is the unique international strategic forum for global health. It brings together stakeholders from politics, science, the private sector, and civil society from around the wor...
bit.ly
October 9, 2025 at 11:05 AM
Will you be in Berlin for the @worldhealthsummit.bsky.social?
CEPI is organising a thought-provoking panel entitled “Preparing for Future Pandemics – From Fragmentation to Cohesion” on 12 October 2025, 16:00–17:30 CEST ⬇️
bit.ly/3WvE9TI
CEPI is organising a thought-provoking panel entitled “Preparing for Future Pandemics – From Fragmentation to Cohesion” on 12 October 2025, 16:00–17:30 CEST ⬇️
bit.ly/3WvE9TI